News Image

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Provided By GlobeNewswire

Last update: Nov 1, 2024

The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients

Read more at globenewswire.com

ENVOY MEDICAL INC

NASDAQ:COCH (8/12/2025, 8:00:01 PM)

After market: 1.42 -0.05 (-3.4%)

1.47

-0.08 (-5.47%)



Find more stocks in the Stock Screener

Follow ChartMill for more